EGFR and neoplasm: Our recent study using endogenously expressed GFP-tagged EGFR allowed the demonstration that low concentrations of EGFR ligands are sufficient to drive EGFR-dependent growth of mouse tumor xenografts and that EGFR endocytosis in tumors in vivo is clathrin-mediated (Pinilla-Macua et al., 2017).